Prazosin Hydrochloride
- Product NDC
- 71610-829
- 11-digit product format
- 716100829
- Labeler code
- 71610
- Product ID
- 71610-829_18680839-460f-1189-e063-6394a90accdf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Prazosin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA214608
- Marketing category
- ANDA
- Marketing start
- 2023-01-17
- Substance
- PRAZOSIN HYDROCHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| X0Z7454B90 | PRAZOSIN HYDROCHLORIDE | 19237-84-4 | PRAZOSIN HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71610-829-27 | 71610082927 | 1250 CAPSULE in 1 BOTTLE (71610-829-27) | 1250 capsule | 2024-05-10 | No | No | Historical |